Trial · NCT00810732
Participant flow90
How many started, completed or left each group, period by period.
61 to 80 of 90
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Placebo Then Sitaxsentan Then Nifedipine | 5 | |
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Sitaxsentan Then Nifedipine Then Placebo | 4 | |
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Nifedipine Then Sitaxsentan Then Placebo | 4 | |
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Nifedipine Then Placebo Then Sitaxsentan | 5 | |
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Placebo Then Nifedipine Then Sitaxsentan | 5 | |
| Second Washout Period (at Least 2 Weeks) | COMPLETED | Sitaxsentan Then Placebo Then Nifedipine | 4 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Placebo Then Sitaxsentan Then Nifedipine | 0 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Sitaxsentan Then Nifedipine Then Placebo | 0 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Nifedipine Then Sitaxsentan Then Placebo | 0 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Nifedipine Then Placebo Then Sitaxsentan | 0 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Placebo Then Nifedipine Then Sitaxsentan | 0 | |
| Second Washout Period (at Least 2 Weeks) | NOT COMPLETED | Sitaxsentan Then Placebo Then Nifedipine | 0 | |
| Third Intervention Period (6 Weeks) | STARTED | Placebo Then Sitaxsentan Then Nifedipine | 5 | |
| Third Intervention Period (6 Weeks) | STARTED | Sitaxsentan Then Nifedipine Then Placebo | 4 | |
| Third Intervention Period (6 Weeks) | STARTED | Nifedipine Then Sitaxsentan Then Placebo | 4 | |
| Third Intervention Period (6 Weeks) | STARTED | Nifedipine Then Placebo Then Sitaxsentan | 5 | |
| Third Intervention Period (6 Weeks) | STARTED | Placebo Then Nifedipine Then Sitaxsentan | 5 | |
| Third Intervention Period (6 Weeks) | STARTED | Sitaxsentan Then Placebo Then Nifedipine | 4 | |
| Third Intervention Period (6 Weeks) | COMPLETED | Placebo Then Sitaxsentan Then Nifedipine | 5 | |
| Third Intervention Period (6 Weeks) | COMPLETED | Sitaxsentan Then Nifedipine Then Placebo | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00810732/flow?page=4